| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 16, 2026 | INCY Incyte Corporation | Issa Mohamed Khairie | EVP, Head Of U.s. Commercial | Sell | 1,093 | $115.01 | $125,705.93 | -1.7% | - | - | |
| Jul 16, 2026 | INCY Incyte Corporation | Stein Steven H53 | CMO &Head Of Late-stage Dev. | Sell | 1,877 | $114.73 | $215,348.21 | -8.2% | - | - | |
| Jul 16, 2026 | BFLY Butterfly Network, Inc. | Rothberg Jonathan M71 | Director, 10% Owner | Sell | 4,013,452 | $7.32 | $29,368,632.46 | -60.8% | - | - | |
| Jul 15, 2026 | KMTS Kestra Medical Technologies, Ltd. | Webster Brian Daniel60 | See Remarks | Sell | 15,000 | $22.44 | $336,609.18 | -0.9% | - | - | |
| Jul 15, 2026 | RDGL Vivos Inc. | Korenko Michael K | CEO And President | Buy | 200,000 | $0.06 | $11,420.00 | +1.8% | - | - | |
| Jul 14, 2026 | STIM Neuronetics, Inc. | Chernett Jorey60 | 10% Owner | Buy | 35,000 | $1.78 | $62,300.00 | +0.3% | - | - | |
| Jul 10, 2026 | RDGL Vivos Inc. | Weeks Brad Allan | President | Buy | 60,000 | $0.08 | $4,800.00 | +3.1% | - | - | |
| Jul 10, 2026 | RDGL Vivos Inc. | Weeks Brad Allan | President | Buy | 60,000 | $0.08 | $4,800.00 | +2.2% | - | - | |
| Jul 9, 2026 | GKOS Glaukos Corporation | Thurman Alex R.50 | SVP &Chief Financial Officer | Sell | 10,000 | $155.00 | $1,550,000.00 | -18.6% | - | - | |
| Jul 8, 2026 | MDT Medtronic Plc | Walter Matthew R. | SVP, Chief Hr Officer | Sell | 3,102 | $83.15 | $257,931.30 | -8.0% | - | - | |
| Jul 8, 2026 | CV Capsovision, Inc. | Harari Eliyahou Et Al | 10% Owner | Buy | 81,300 | $6.09 | $495,117.00 | +2.5% | - | - | |
| Jul 7, 2026 | CBLL Ceribell, Inc. | Chao Xingjuan51 | President And CEO | Sell | 39,000 | $19.90 | $776,100.00 | -1.6% | - | - | |
| Jul 7, 2026 | RSMDF Resmed Inc. | Farrell Michael J.63 | Chairman And CEO | Sell | 4,991 | $218.55 | $1,090,770.57 | -1.1% | - | - | |
| Jul 6, 2026 | GKOS Glaukos Corporation | Thurman Alex R.50 | SVP &Chief Financial Officer | Sell | 10,000 | $150.00 | $1,500,000.00 | -18.6% | - | - | |
| Jul 6, 2026 | SGHT Sight Sciences, Inc. | Badawi David58 | Chief Technology Officer | Sell | 7,418 | $5.51 | $40,858.34 | -0.4% | - | - | |
| Jul 6, 2026 | WRBY Warby Parker Inc. | Gilboa David Abraham62 | Co-chief Executive Officer | Sell | 54,347 | $29.84 | $1,621,714.48 | -63.6% | - | - | |
| Jul 6, 2026 | SGHT Sight Sciences, Inc. | Hayden Jeremy B.61 | Chief Legal Officer | Sell | 12,733 | $5.51 | $70,133.36 | -3.4% | - | - | |
| Jul 6, 2026 | WRBY Warby Parker Inc. | Blumenthal Neil Harris65 | Co-chief Executive Officer | Sell | 9,200 | $29.99 | $275,908.00 | -22.8% | - | - | |
| Jul 2, 2026 | SGHT Sight Sciences, Inc. | Bauerlein Alison71 | Chief Operating Officer | Sell | 24,184 | $5.36 | $129,626.24 | -3.5% | - | - | |
| Jul 2, 2026 | SGHT Sight Sciences, Inc. | Rodberg James54 | Chief Financial Officer | Sell | 6,902 | $5.36 | $36,994.72 | -3.0% | - | - | |
| Jul 1, 2026 | GKOS Glaukos Corporation | Navratil Tomas59 | Chief Development Officer | Sell | 716 | $139.06 | $99,566.96 | -0.8% | - | - | |
| Jul 1, 2026 | SGHT Sight Sciences, Inc. | Taylor Brenton74 | EVP, Operations &R&D | Sell | 2,829 | $5.42 | $15,333.18 | -1.1% | - | - | |
| Jul 1, 2026 | SGHT Sight Sciences, Inc. | Badawi Paul60 | President And CEO | Sell | 28,684 | $5.42 | $155,467.28 | -0.5% | - | - | |
| Jun 30, 2026 | EW Edwards Lifesciences Corporation | Lippis Daniel J.61 | Cvp, Tavr | Sell | 619 | $91.40 | $56,576.72 | -1.5% | - | - | |
| Jun 29, 2026 | BBNX Beta Bionics, Inc. | Feider Stephen71 | Chief Financial Officer | Sell | 10,000 | $17.04 | $170,387.20 | -2.9% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.